These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18157525)

  • 21. Cigarette smoking and heavy coffee consumption affecting response to olanzapine: The role of genetic polymorphism.
    Djordjevic N; Radmanovic B; Cukic J; Baskic D; Djukic-Dejanovic S; Milovanovic D; Aklillu E
    World J Biol Psychiatry; 2020 Jan; 21(1):29-52. PubMed ID: 30513034
    [No Abstract]   [Full Text] [Related]  

  • 22. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
    Kotsopoulos J; Ghadirian P; El-Sohemy A; Lynch HT; Snyder C; Daly M; Domchek S; Randall S; Karlan B; Zhang P; Zhang S; Sun P; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):912-6. PubMed ID: 17507615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYP1A2 in a smoking and a non-smoking population; correlation of urinary and salivary phenotypic ratios.
    Woolridge H; Williams J; Cronin A; Evans N; Steventon GB
    Drug Metabol Drug Interact; 2004; 20(4):247-61. PubMed ID: 15663294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of age and smoking on in vivo CYP1A2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: determination by caffeine metabolism.
    Chung WG; Kang JH; Park CS; Cho MH; Cha YN
    Clin Pharmacol Ther; 2000 Mar; 67(3):258-66. PubMed ID: 10741629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CYP1A2 polymorphisms modify the association of habitual coffee consumption with appetite, macronutrient intake, and body mass index: results from an observational cohort and a cross-over randomized study.
    Gkouskou KG; Georgiopoulos G; Vlastos I; Lazou E; Chaniotis D; Papaioannou TG; Mantzoros CS; Sanoudou D; Eliopoulos AG
    Int J Obes (Lond); 2022 Jan; 46(1):162-168. PubMed ID: 34564706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol.
    Le Marchand L; Franke AA; Custer L; Wilkens LR; Cooney RV
    Pharmacogenetics; 1997 Feb; 7(1):11-9. PubMed ID: 9110357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of caffeine intake and CYP1A2 genotype with ovarian cancer.
    Goodman MT; Tung KH; McDuffie K; Wilkens LR; Donlon TA
    Nutr Cancer; 2003; 46(1):23-9. PubMed ID: 12925300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraxanthine/caffeine ratio: as an index for CYP1A2 activity in polycyclic aromatic hydrocarbons exposed subjects.
    Wittayalertpanya S; Hinsui Y; Lawanprasert S
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S310-7. PubMed ID: 12930004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caffeine induces CYP1A2 expression in rat hepatocytes but not in human hepatocytes.
    Vaynshteyn D; Jeong H
    Drug Metab Lett; 2012 Jun; 6(2):116-9. PubMed ID: 23167901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of caffeine as a probe for rapid determination of cytochrome P-450 CYP1A2 activity in humans.
    Ou-Yang DS; Huang SL; Xie HG; Wang CY; Zhou HH
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):44-6. PubMed ID: 10375757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2.
    Chuang YH; Lill CM; Lee PC; Hansen J; Lassen CF; Bertram L; Greene N; Sinsheimer JS; Ritz B
    Neuroepidemiology; 2016; 47(3-4):192-200. PubMed ID: 28135712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype.
    Lowcock EC; Cotterchio M; Anderson LN; Boucher BA; El-Sohemy A
    Nutr Cancer; 2013; 65(3):398-409. PubMed ID: 23530639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coffee, CYP1A2 genotype, and risk of myocardial infarction.
    Cornelis MC; El-Sohemy A; Kabagambe EK; Campos H
    JAMA; 2006 Mar; 295(10):1135-41. PubMed ID: 16522833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension.
    Palatini P; Ceolotto G; Ragazzo F; Dorigatti F; Saladini F; Papparella I; Mos L; Zanata G; Santonastaso M
    J Hypertens; 2009 Aug; 27(8):1594-601. PubMed ID: 19451835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term coffee consumption, caffeine metabolism genetics, and risk of cardiovascular disease: a prospective analysis of up to 347,077 individuals and 8368 cases.
    Zhou A; Hyppönen E
    Am J Clin Nutr; 2019 Mar; 109(3):509-516. PubMed ID: 30838377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A population and family study of CYP1A2 using caffeine urinary metabolites.
    Catteau A; Bechtel YC; Poisson N; Bechtel PR; Bonaïti-Pellie C
    Eur J Clin Pharmacol; 1995; 47(5):423-30. PubMed ID: 7720764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status.
    Bågeman E; Ingvar C; Rose C; Jernström H
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):895-901. PubMed ID: 18398030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Habitual coffee consumption and risk of dementia in older persons: modulation by CYP1A2 polymorphism.
    Lefèvre-Arbogast S; Helmer C; Berr C; Debette S; Samieri C
    Eur J Epidemiol; 2024 Jan; 39(1):81-86. PubMed ID: 37906419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of cytochrome P450 oxidoreductase genetic polymorphisms on CYP1A2 activity and inducibility by smoking.
    Dobrinas M; Cornuz J; Pedrido L; Eap CB
    Pharmacogenet Genomics; 2012 Feb; 22(2):143-51. PubMed ID: 22246422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status.
    Simonsson M; Söderlind V; Henningson M; Hjertberg M; Rose C; Ingvar C; Jernström H
    Cancer Causes Control; 2013 May; 24(5):929-40. PubMed ID: 23412805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.